Holdings (as at 2026-06-25)
Percentage of net assets may not equal 100%
Security Name % of Net Assets
Humana Inc. 4.52%
Organon & Co. 3.75%
DaVita Inc. 2.90%
Elevance Health Inc. 2.76%
Molina Healthcare, Inc. 2.70%
Exelixis, Inc. 2.59%
Solventum Corporation 2.49%
Incyte Corporation 2.38%
Cardinal Health, Inc. 2.31%
Biogen Inc. 2.30%
Bio-Rad Laboratories, Inc. (Class A) 2.23%
The Cigna Group 2.21%
Zimmer Biomet Holdings, Inc. 2.10%
Globus Medical, Inc. (Class A) 2.05%
Chemed Corporation 2.00%
Illumina, Inc. 1.80%
Merck & Co., Inc. 1.74%
Ionis Pharmaceuticals, Inc. 1.74%
Encompass Health Corporation 1.72%
HCA Healthcare, Inc. 1.71%
Universal Health Services, Inc. (Class B) 1.68%
Amgen Inc. 1.67%
Regeneron Pharmaceuticals, Inc. 1.67%
Natera, Inc. 1.63%
QIAGEN N.V. 1.62%
Tenet Healthcare Corporation 1.62%
Revvity, Inc. 1.62%
Becton, Dickinson and Company 1.61%
Penumbra, Inc. 1.61%
United Therapeutics Corporation 1.53%
Henry Schein, Inc. 1.42%
Pfizer Inc. 1.41%
Quest Diagnostics Incorporated 1.32%
UnitedHealth Group Incorporated 1.28%
Labcorp Holdings Inc. 1.25%
The Cooper Companies, Inc. 1.24%
Certara, Inc. 1.20%
Steris Plc 1.19%
Medtronic Plc 1.16%
Bristol-Myers Squibb Company 1.14%
GE HealthCare Technologies Inc. 1.14%
ResMed Inc. 1.11%
Gilead Sciences, Inc. 1.11%
Insmed Incorporated 1.06%
Waters Corporation 1.05%
Neurocrine Biosciences, Inc. 1.04%
Eli Lilly and Company 1.01%
Agilent Technologies, Inc. 0.99%
Halozyme Therapeutics, Inc. 0.94%
Sarepta Therapeutics, Inc. 0.92%
IQVIA Holdings Inc. 0.91%
Medpace Holdings, Inc. 0.91%
Align Technology, Inc. 0.86%
Thermo Fisher Scientific Inc. 0.85%
BioMarin Pharmaceutical Inc. 0.85%
Johnson & Johnson 0.84%
Abbott Laboratories 0.76%
Medline Inc. (Class A) 0.71%
Zoetis Inc. 0.55%
West Pharmaceutical Services, Inc. 0.54%
Sotera Health Company 0.47%
Royalty Pharma Plc (Class A) 0.45%
Edwards Lifesciences Corporation 0.44%
AbbVie Inc. 0.44%
Viking Therapeutics, Inc. 0.44%
DexCom, Inc. 0.43%
Vertex Pharmaceuticals Incorporated 0.42%
Envista Holdings Corporation 0.41%
Danaher Corporation 0.40%
IDEXX Laboratories, Inc. 0.39%
Stryker Corporation 0.38%
Veeva Systems Inc. (Class A) 0.35%
Intuitive Surgical, Inc. 0.34%
Alnylam Pharmaceuticals, Inc. 0.34%
Boston Scientific Corporation 0.28%

Holdings are subject to change.

Commissions, management fees and expenses all may be associated with Exchange-Traded Fund investments. Please carefully read the prospectus of the fund before investing. Exchange-Traded funds are not guaranteed, their values change frequently and past performance may not be repeated.